Iovance Biotherapeutics Inc. Common Stock vs The Travelers Companies Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.45 (market cap $6.04B), while The Travelers Companies Inc. Common Stock trades at $368.75 (market cap $77.23B). The key difference: The Travelers Companies Inc. Common Stock is far larger — about 12.8× Iovance Biotherapeutics Inc. Common Stock's market cap, and The Travelers Companies Inc. Common Stock pays a 1.35% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and The Travelers Companies Inc. Common Stock for 0 Days on average.
| IOVA | TRV | |
|---|---|---|
Market Cap | $6.04B | $77.23B |
Volume | 14,805,993 | 1,078,682 |
Sector | Health | Financials |
52-Week High | $14.82 | $397.22 |
52-Week Low | $1.81 | $261.57 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $85.82B |
Dividend Yield | — | 1.35% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.
Read more on TRV →